Ogast and encephalopathy Patient Reports February 10, 2010

Ogast Side Effects Report #4738299-4
Ogast side effect was reported by a Consumer or non-health professional from FRANCE on July 29, 2005. Female patient, 72 years of age, was diagnosed with oesophagitis and was treated with Ogast. After drug was administered, patient experienced the following side effects: breast cancer stage iii, coma, encephalopathy. Ogast dosage: 30 MG (30 MG, 1 IN 1 D) ORAL. During the same period patient was treated with ALLOPURINOL, PREVISCAN, FUROSEMIDE, ALDACTONE. Patient was hospitalized. Patient recovered.